Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$sbfm](/topic/$sbfm)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$sbfm/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$sbfm/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +50%  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-09-26  

**Most Supportive Themes**
- **Positive Sentiment and Engagement Surge:** (40%) Posts highlight increased engagements and positive sentiment surrounding $SBFM, indicating growing interest.
- **NIOPEG Launch:** (30%) The launch of NIOPEG, a biosimilar, is seen as a positive development for Sunshine Biopharma.
  
**Most Critical Themes**
- **Declining Community Growth:** (30%)  Despite engagement increases, community growth is uncertain with mentions of other assets and declining creator activity.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$sbfm

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XXX% no change
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-26

Most Supportive Themes

  • Positive Sentiment and Engagement Surge: (40%) Posts highlight increased engagements and positive sentiment surrounding $SBFM, indicating growing interest.
  • NIOPEG Launch: (30%) The launch of NIOPEG, a biosimilar, is seen as a positive development for Sunshine Biopharma.

Most Critical Themes

  • Declining Community Growth: (30%) Despite engagement increases, community growth is uncertain with mentions of other assets and declining creator activity.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XXX X%
Total XXXXX XX% XXXXX XX% XXX X%
$sbfm Sentiment
/topic/$sbfm/sentiment